Navigation Links
Otonomy Presents Positive New Findings From Phase 1b Study of OTO-104 in Meniere's Disease at International Conference
Date:9/29/2011

#160;According to the National Institute on Deafness and Other Communication Disorders (NIDCD), approximately 615,000 individuals have been diagnosed with Meniere's disease in the United States.

About OtonomyOtonomy is a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear.  There are currently no FDA-approved drug treatments for the nearly 30 million Americans that are affected by debilitating hearing and balance diseases and disorders such as Meniere's disease, sudden sensorineural hearing loss, noise-induced hearing loss, age-related hearing impairment and tinnitus.  Otonomy's core technology is a sustained release formulation developed for optimal delivery of drugs to the middle and inner ear with a single IT injection.  This technology has broad applicability across a range of therapeutic classes and two products based on this platform are in active development.

Otonomy's lead product candidate, OTO-104, is a sustained release formulation of the steroid dexamethasone.  The company has finalized plans for a Phase 2 clinical trial in Meniere's disease patients and plans to initiate the study during the fourth quarter of 2011.  Additional future studies of OTO-104 are being planned in other inner ear disorders.  OTO-201, the company's second product candidate, is a novel sustained release antibiotic being developed in the field of otitis media.  OTO-201 clinical trials are expected to begin in 2011.  Additional product candidates are expected to target acute and chronic forms of hearing loss, balance disorders, and tinnitus.

For more information visit: www.otonomy.com.Contact:Vida Communication (On behalf of Otonomy)Stephanie Diaz (investors)

Tim Brons (media)415-675-7400

415-675-7400sdiaz@vidacommunication.com

'/>"/>

SOURCE Otonomy, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Otonomy Introduces Scientific Advisory Board
2. Otonomys OTO-104 Demonstrates Hearing Loss Protection and Hearing Recovery in Preclinical Studies
3. Otonomy Appoints Gerald Wroblewski as Chief Operations Officer
4. Bluestar Silicones Presents Adhesive Gels for Wound Care at Medical Grade Polymers Conference
5. Acologix Presents Preclinical Data on Cartilage Regeneration by AC-100 at the 30th ASBMR Annual Meeting
6. Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice
7. MedImmune Presents Data at AAP National Conference & Exhibition Demonstrating Burden of RSV Disease
8. GeoVax Presents Data at AIDS Vaccine 2008 Conference
9. Dendreon Presents Preclinical Data Validating Anti-Tumor Activity of D-3263, a Trp-p8 Agonist
10. MedImmune Presents Data Highlighting its Progressive Inflammatory Disease Portfolio at the 72nd Annual Meeting of the American College of Rheumatology
11. Northern Antibiotics Presents New Data on Novel Polymyxin Compounds at the Joint ICAAC/IDSA 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... e2b teknologies , a premier Sage ... Ohio, today announced a leading independent multi-specialty physician group ... to the latest version of Sage 100 ERP ... its kind in the region, the organization has an ... efficiency and data accessibility are paramount to their ongoing ...
(Date:3/4/2015)... BALTIMORE , March 4, 2015 In ... at the UPMC Center for Health Security review the ... that can be used as bioweapons. The article, "Clinical ... online today on the website of the New ... authors—Amesh Adalja, Eric Toner , and Tom Inglesby—review ...
(Date:3/4/2015)... Research and Markets ( http://www.researchandmarkets.com/research/nqxxt3/biomarkers ... new report "Biomarkers - Technologies, Markets and ... This report follows the broad definition of a ... measured and evaluated as an indicator of normal ... responses to a therapeutic intervention. Tests based on ...
(Date:3/4/2015)... 2015 Proove Biosciences , ... is excited to announce the launch of their ... the Management of Pain”. , The continuing medical ... the next year. The focus of the program ... inadequate pain treatments, integrate appropriate pain management techniques, ...
Breaking Biology Technology:Physician Group Practice Chooses e2b teknologies to Support Its Upgrade to Sage 100 ERP 2014 2Latest Clinical Information On Bioterrorism Threats 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 3Proove Biosciences Launches CME Accredited Program with Medscape 2Proove Biosciences Launches CME Accredited Program with Medscape 3
... exclusive interview with new TDS Telecom CEO Dave Wittwer, ... from a phone company to a broadband provider. In this second ... and explains why every TDS employee has a role to play ... , , WTN: How would you describe your approach to ...
... four-part series on intellectual property law. In part I ... risk in copyright cases. In this presentation, she does the ... Liability for officers and directors , , In ... to be personally liable, he or she must personally take ...
... Madison, Wis . - As a result of the ... a Chicago data security provider, the Madison-based network operations ... ,Ambiron, which serves businesses in the payment card industry, ... managed security provider with most of its 50 employees ...
Cached Biology Technology:New CEO at TDS on creating a culture of innovation (Part 2) 2New CEO at TDS on creating a culture of innovation (Part 2) 3New CEO at TDS on creating a culture of innovation (Part 2) 4Intellectual Property: Are you an infringer? 2Intellectual Property: Are you an infringer? 3Intellectual Property: Are you an infringer? 4Sale of SecurePipe won't result in Madison layoffs 2
(Date:2/25/2015)... , Feb. 25, 2015  ABC Financial ... billing in the Health and Fitness Industry, today ... as to MYiCLUBonline.  The latest upgrade includes advances ... inclusion of cardless check-in via Identity One fingerprint ... first time through interactive displays at the International ...
(Date:2/23/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market, ... for DISTRIBUTED VOICE DIRECTED PAYMENT METHOD AND ... new groundbreaking payment method. Payment accounts may be selected ... be accessed if both the speech (the word associated ...
(Date:2/12/2015)...   MedNet Solutions , a global life ... systems, has recently bolstered its iMedNet™ ... iMedNet as the eClinical solution of ... consultants.  Building on the Program,s existing benefits (including ... co-marketing opportunities), MedNet,s new and improved program provides ...
Breaking Biology News(10 mins):ABC Financial Unveils New Software Enhancements 2ABC Financial Unveils New Software Enhancements 3NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2
... known that cramming is not an effective way to ... RIKEN Brain Science Institute in Japan, studying eye movement ... explaining why this is so. Published in the ... synthesis in the cerebellum plays a key role in ...
... of Exeter biologist has discovered a ,lost, species of bat breeding ... bat is the first of its species to be found on ... Dr Fiona Mathews, Senior Lecturer at the University of Exeter, a ... The Scilly Isles Bat Group called in Dr Mathews and her ...
... of Medicine of the University of Southern California (USC) ... Parkinson,s disease (PD), which ultimately could lead to finding ... alpha-synuclein (α-synuclein) protein is commonly found in the healthy ... The protein has been the subject of substantial Parkinson,s ...
Cached Biology News:A better way to remember 2'Lost' bats found breeding on Scilly 2USC researchers find new clues about protein linked to Parkinson's disease 2
...
Sterile detoxified 10% bovine serum albumin (BSA) in Iscoves MDM. This BSA has been selected to support the optimal colony growth of human hematopoietic progenitor cells in methylcellulose-based medi...
... high-performance ICP-MS system designed for flexibility and ... II off-axis ion lens, true hyperbolic quadrupole ... handle the widest range of sample types ... now includes as standard Agilents unique ShieldTorch ...
... to the DH-2000, except that it uses a ... wavelength range and comes with a shutter (controlled ... 5 Hz) The DH-2000 Deuterium Tungsten ... deuterium and tungsten halogen light sources in a ...
Biology Products: